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Background: Folate, vitamin B-12, and vitamin B-6 are essential nutritional components in one-carbon metabolism
and are required for methylation capacity. The availability of these vitamins may therefore modify methylation of
phosphatidylethanolamine (PE) to phosphatidylcholine (PC) by PE-N-methyltransferase (PEMT) in the liver. It has
been suggested that PC synthesis by PEMT plays an important role in the transport of polyunsaturated fatty acids
(PUFAs) like docosahexaenoic acid (DHA) from the liver to plasma and possibly other tissues. We hypothesized that
if B-vitamin supplementation enhances PEMT activity, then supplementation could also increase the concentration
of plasma levels of PUFAs such as DHA. To test this hypothesis, we determined the effect of varying the combined
dietary intake of these three B-vitamins on plasma DHA concentration in rats.
Methods: In a first experiment, plasma DHA and plasma homocysteine concentrations were measured in rats that
had consumed a B-vitamin-poor diet for 4 weeks after which they were either continued on the B-vitamin-poor
diet or switched to a B-vitamin-enriched diet for another 4 weeks. In a second experiment, plasma DHA and plasma
homocysteine concentrations were measured in rats after feeding them one of four diets with varying levels of B-
vitamins for 4 weeks. The diets provided 0% (poor), 100% (normal), 400% (enriched), and 1600% (high) of the
laboratory rodent requirements for each of the three B-vitamins.
Results: Plasma DHA concentration was higher in rats fed the B-vitamin-enriched diet than in rats that were
continued on the B-vitamin-poor diet (P= 0.005; experiment A). Varying dietary B-vitamin intake from deficient to
supra-physiologic resulted in a non-linear dose-dependent trend for increasing plasma DHA (P= 0.027; experiment
B). Plasma DHA was lowest in rats consuming the B-vitamin-poor diet (P> 0.05 vs. normal, P< 0.05 vs. enriched and
high) and highest in rats consuming the B-vitamin-high diet (P< 0.05 vs. poor and normal, P> 0.05 vs. enriched). B-
vitamin deficiency significantly increased plasma total homocysteine but increasing intake above normal did not
significantly reduce it. Nevertheless, in both experiments plasma DHA was inversely correlated with plasma total
homocysteine.
Conclusion: These data demonstrate that dietary folate, vitamin B-12, and vitamin B-6 intake can influence plasma
concentration of DHA.
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Several clinical studies in different populations have
found a negative correlation between serum, plasma or
erythrocyte content of docosahexaenoic acid (DHA) and
markers of B-vitamin deficiency such as plasma levels of
homocysteine and/or S-adenosylhomocysteine (SAH) [1-
3]. In line with these observations, dietary deficiency
studies in rats have shown that deficiencies of folate,
vitamin B-12, or vitamin B-6 may reduce peripheral
DHA levels [4-6]. Although these data indicate a link be-
tween dietary B-vitamin intake and DHA status, it has
not been studied whether concurrently varying the diet-
ary intake of folic acid, vitamin B-12, and vitamin B-6
could influence plasma DHA concentration.
Hypothetically, dietary B-vitamin availability might in-
fluence plasma DHA by influencing synthesis of phos-
phatidylcholine (PC) in the liver. Hepatic PC can be
synthesized by two different metabolic pathways, the
cytidine diphosphate (CDP)-choline pathway (Kennedy
cycle) and the phosphatidylethanolamine-N-methyltrans-
ferase (PEMT) pathway. The CDP-choline pathway uti-
lizes 1,2-diacylglycerol and CDP-choline for the
synthesis of PC [7], whereas PEMT catalyzes the sequen-
tial methylation of phosphatidylethanolamine (PE) to PC
[8]. It has been suggested that the methylation of PE to
PC by PEMT plays an important role in the transport of
polyunsaturated fatty acids (PUFAs) like DHA from the
liver to the plasma and other tissues [3,9,10]. Most likely,
two mechanisms are involved. First, PC synthesis is
required for normal secretion of very low density lipo-
protein (VLDL) from liver cells [11]. An impairment of
the PEMT pathway results in a diminished PC synthesis
and therefore limits hepatic secretion of VLDL [12]. Be-
cause VLDL is the main carrier of endogenous triglycer-
ides, phospholipids, and cholesterol esters, impairment
of the PEMT pathway directly affects the transport of
these components from the liver to peripheral tissues
[13]. Second, PC synthesized by the PEMT pathway con-
tains more PUFAs such as DHA than does PC synthe-
sized by the CDP-choline pathway because PEMT
prefers species of PE containing PUFAs [10,14,15].
Hence, PEMT activity can influence both VLDL secre-
tion and the rate of synthesis of PUFA-rich PC species.
Therefore, a factor that influences hepatic PEMT activity
could potentially affect the availability of PUFAs such as
DHA in plasma [9] and even their transport to the brain
[16].
Folate, vitamin B-12, and vitamin B-6 availability are
important determinants of methionine and S-adenosyl-
methionine (SAM) synthesis and of SAH and homocyst-
eine clearance, and therefore of methylation capacity.
Thus, B-vitamin availability can be hypothesized to dir-
ectly modify liver PEMT activity and PEMT-dependent
PUFA secretion. This in turn, is predicted to influenceplasma PUFA concentration and thus tissue availability.
If so, then adequate dietary intake of these three vita-
mins would be necessary to maintain normal plasma
DHA concentrations, and increasing dietary intake
above the normal range might be expected to increase
plasma DHA. The aim of the present study was to deter-
mine whether dietary enrichment with the combination
of these three B-vitamins could increase plasma DHA
concentration in rats. In a first experiment, plasma DHA
concentration was measured in rats that had consumed
a B-vitamin-poor diet for 4 weeks, after which they were
either continued on the B-vitamin-poor diet or switched
to a B-vitamin-enriched diet for another 4 weeks. In a
second experiment, the dependency of plasma DHA on
dietary B-vitamin content was determined by feeding
rats for 4 weeks one of four diets containing varying
levels of the B-vitamins across the range from inad-
equate to supra-physiological.
Methods
Two experiments were conducted to investigate the
effects of varying dietary levels of folate, vitamin B-12,
and vitamin B-6 on plasma DHA concentration. Experi-
ment A was conducted at the Department of Brain and
Cognitive Sciences, Massachusetts Institute of Technol-
ogy (Cambridge, MA, USA). Experiment B was con-
ducted at the Centrum Kleine Proefdieren, Wageningen
University (Wageningen, The Netherlands).
Animals
A total of sixty-four male Sprague–Dawley rats (Crl:CD
(SD)) were obtained from either Charles River, Wilming-
ton, MA, USA (experiment A; n=16) or Charles River,
Sulzfeld, Germany (experiment B; n=48). Animals aged
6–8 weeks on arrival were housed in groups in a
temperature- and light-controlled room, under 12 h light–
12 h dark cycles. Rats had free access to food and water.
Body weight was registered once a week. All animal ex-
perimental protocols were conducted in accordance with
international and national laws and institutional guidelines
and approved by the local ethics committee, i.e. the Com-
mittee on Animal Care at Massachusetts Institute of
Technology, Cambridge, MA, USA (experiment A) and
DEC Consult, Bilthoven, The Netherlands (experiment B).
Diets
Four different diets with increasing folate, vitamin B-12,
and vitamin B-6 contents were used: 1) B-vitamin-poor;
2) B-vitamin-normal; 3) B-vitamin-enriched; and 4) B-
vitamin-high. Diets were AIN-93 M based [17], isoener-
getic, and identical with respect to their protein, carbo-
hydrate, fat, fiber, and mineral contents. All diets were
devoid of any measurable amounts of DHA. The vitamin
mix (AIN-93-VX) [17] was prepared without folic acid,
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subsequently supplemented accordingly. Diets were for-
mulated with vitamin-free, ethanol-precipitated casein
(Harlan Teklad, Madison, WI, USA) and were manufac-
tured by Research Diet Services, Wijk bij Duurstede,
The Netherlands (experiment A) and Ssniff Spezialdiä-
ten, Soest, Germany (experiment B).
The B-vitamin-poor diet contained low amounts of
folate (<0.1 mg/kg), vitamin B-12 (<1.0 μg/kg), and vita-
min B-6 (<0.6 mg/kg). No sulfathiazole drugs were
added to the diet and therefore a limited amount of fol-
ate was still expected to be provided by the gut flora.
Vitamin B-12 deficiency in the rat is difficult to achieve
because of considerable endogenous storage of this vita-
min. To attain a moderate reduction of endogenous vita-
min B-12, the B-vitamin-poor was supplemented with
50 g/kg pectin (polygalacturonic acid, high methoxyl,
ObipektinW, NF/USP Citrus; TEFCO FoodIngredients,
Bodegraven, The Netherlands), which binds vitamin B-
12 in the intestine, making it less bioavailable [18]. Pec-
tin consequently promotes depletion of endogenous vita-
min B-12 through the enterohepatic circulation of the
vitamin. Since pectin could affect food intake [19], all
four diets were supplemented with pectin to maintain
uniform intakes of the diets. Pectin has minimal effects
on vitamin B-12 status when the diet contains adequate
amounts of this vitamin [18].
The B-vitamin-normal diet, the B-vitamin-enriched diet,
and the B-vitamin-high diet provided 100%, 400%, and
1600%, respectively, of the requirements for each of the
three vitamins according to the National Research Council
report on the nutrient requirements of laboratory animals
[20]. The exact dietary levels of the three B-vitamins in
each experimental diet are indicated in Table 1.
Experimental design
In experiment A, B-vitamin paucity was first induced in
all rats by feeding them the B-vitamin-poor diet for
4 weeks. Subsequently, animals were either continued on
the B-vitamin-poor diet or switched to the B-vitamin-
enriched diet for another 4 weeks. In experiment B rats
were directly fed one of the four experimental diets for
4 weeks.Table 1 Folate, vitamin B-12, and vitamin B-6 content of the
Diet description
Folate (folic acid)




B-vitamin-high 1600% 16.0Tissue preparation
After the supplementation period, animals that had been
feed-deprived for 3–4 hours were killed by CO2 gas inhal-
ation (experiment A) or by inhalation of isoflurane vapor-
ized in medicinal air (experiment B) and subsequent
decapitation by guillotine. Trunk blood was collected
through a funnel into EDTA-containing tubes. After cen-
trifugation at 1750× g for 10 min, plasma was aspirated
and analyzed for plasma DHA and homocysteine.
Plasma DHA and plasma total homocysteine analysis
Plasma total lipid DHA was detected using GC. Total
lipid content was extracted from plasma by adding
methanol and dichloromethane. Samples were subse-
quently centrifuged at 1750 × g for 10 min and the or-
ganic phase (dichloromethane and lipids) was collected.
200 μL of the dichloromethane layer was dried using a
SpeedVacW concentrator. Next, 2.0 mL methanol and 40
μL concentrated sulfuric acid were added to the dried
extract. The samples were heated at 100 °C for 60 min,
and 2 mL hexane and 0.5 mL 2.5 mol/L sodium hydrox-
ide solution were added. After vortexing and centrifu-
ging the samples for 5 min at 1750 × g, the upper layer
was collected and dried using a SpeedVacW. Dried sam-
ples were subsequently dissolved in 125 μL iso-octane
and analyzed by GC using flame ionization detection.
Plasma total homocysteine was determined by fluoro-
metric HPLC as previously described [21]. Briefly, thiol
amino acids (free and protein-bound) were reduced with
tri-n-butylphosphine. After protein precipitation and
centrifugation to remove the proteins, thiol groups were
derivatized with 7-fluoro-2-oxa-1,3-diazole-4-sulfona-
mide reagent. The content of the derivatized thiol amino
acids was determined by fluorescence detection with ex-
citation at 385 nm and emission at 515 nm.
Statistical methods
All statistical analyses were performed using SPSS (ver-
sion 15.0, SPSS Inc., Chicago, IL, USA). Data were
expressed as means ± SEM. P-values <0.05 were consid-
ered significant. Effects of dietary B-vitamins on body
weight were analyzed using repeated-measures ANOVA
with dietary B-vitamins as between-subject factor andexperimental diets.
Calculated dietary levels
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cysteine concentration were compared between rats fed
the diets varying in B-vitamin content using ANOVA
and post hoc comparisons were performed when appro-
priate. Standard Pearson correlation coefficients were
calculated for plasma DHA and homocysteine.
Results
Experiment A
After feeding all animals the B-vitamin-poor diet for
4 weeks, they were randomized into the two experimental
groups according to their body weight. During the 4 week
intervention period body weight was unaffected by the
level of dietary B-vitamins (F(1,14) = 0.77, P=0.40). After
the 4 week intervention period, plasma DHA concentra-
tion was 72% higher in rats fed the B-vitamin-enriched
diet (176.2± 18.3 μM) than in rats that were continued on
the B-vitamin-poor diet (102.6± 12.5 μM; F(1,14) = 10.97,
P=0.005; Figure 1A). In addition, plasma total homocyst-
eine concentration was lower in animals receiving the B-
vitamin-enriched diet (6.1 ± 0.4 μM) as compared to the
B-vitamin-poor group (10.7 ± 0.8 μM) (F(1,14) = 29.35,
P< 0.001; Figure 1B). A significant inverse correlation was
observed between plasma concentrations of DHA and
homocysteine (r=−0.73, P=0.001; Figure 1C).
Experiment B
Animals were randomized into the four experimental
groups according to their body weights at the start of
the intervention period. Body weight did not differ
between the experimental groups fed the four different
diets for 4 weeks (F(3,44) = 0.16, P= 0.92). After the
intervention period, plasma DHA concentration was
found to be dependent on dietary B-vitamin intake
(F(3,44) = 3.37, P=0.027; Figure 2A). Plasma DHA showed
a non-linear dose-dependent relationship to dietary B-Figure 1 Experiment A: effects of dietary folate, vitamin B-12, and vit
Plasma DHA (A) and plasma total homocysteine (B) concentrations and the
B-vitamin-poor diet for 8 weeks (poor) or a B-vitamin-poor diet for 4 weeks
are means, with the SEM represented by vertical bars. Different letters indic
experimental group).vitamin intake. Compared with rats consuming B-
vitamin-normal diet (125.4 ± 8.0 μM) and B-vitamin-
enriched diet (143.8 ± 9.0 μM), plasma DHA was
reduced in rats consuming the B-vitamin-poor diet
(111.9 ± 10.3 μM, P> 0.05 vs. normal, P< 0.05 vs.
enriched) and increased in rats consuming the B-
vitamin-high diet (157.1 ± 14.9 μM, P< 0.05 vs. normal,
P> 0.05 vs. enriched). Dietary B-vitamin intake also
affected plasma total homocysteine (F(3,44) = 16.18,
P< 0.001; Figure 2B). Plasma homocysteine was increased
in rats fed the B-vitamin-poor diet (11.7 ± 1.5 μM) as
compared with rats fed the B-vitamin-normal diet
(6.0 ± 0.5 μM, P< 0.05), whereas the B-vitamin-enriched
(5.0± 0.2 μM) and B-vitamin-high (5.1± 0.3 μM) diet fur-
ther reduced plasma homocysteine as compared with the
B-vitamin-normal group although this reduction was not
significant (P> 0.05 vs. enriched, P> 0.05 vs. high).
Plasma DHA and homocysteine showed a significant in-
verse correlation (r=−0.29, P=0.043; Figure 2C).Discussion
The present results show that concurrently varying the
dietary intake of folate, vitamin B-12, and vitamin B-6,
across the range from inadequate to supra-physiological
supplementation, can dose-dependently modify plasma
DHA concentration. Experiment A demonstrates that
plasma DHA concentration is dependent on dietary in-
take of folate, vitamin B-12, and vitamin B-6 in rats. Rats
receiving the B-vitamin-enriched diet showed higher
plasma DHA and lower plasma homocysteine concen-
trations as compared to rats that were continued on the
B-vitamin-poor diet. In experiment B the observations
of experiment A were replicated and extended by show-
ing a positive dose–response relationship between diet-
ary B-vitamins and plasma DHA concentration. Plasma
DHA and plasma homocysteine concentrations wereamin B-6 on plasma DHA and homocysteine concentrations.
ir correlation (C; r=−0.73, P= 0.001) in rats that received either a
followed by a B-vitamin-enriched diet for 4 weeks (enriched). Values
ate mean values were significantly different (P< 0.01, n= 8 per
Figure 2 Experiment B: dietary folate, vitamin B-12, and
vitamin B-6 intake dose-dependently modifies plasma DHA
concentration. Plasma DHA (A) and plasma total homocysteine
(B) concentrations and their correlation (C; r=−0.29, P= 0.043) in rats
that received one of the four experimental diets with varying doses
of folate, vitamin B-12, and vitamin B-6 for 4 weeks. Values are
means, with the SEM represented by vertical bars. Different letters
indicate mean values were significantly different (P< 0.05, n= 12 per
experimental group).
van Wijk et al. Nutrition & Metabolism 2012, 9:49 Page 5 of 8
http://www.nutritionandmetabolism.com/content/9/1/49comparable between animals fed the B-vitamin-poor diet
for either 4 weeks (Experiment B) or 8 weeks (Experiment
A). In addition, plasma homocysteine concentrations wereonly moderately increased by the B-vitamin-poor diet and
therefore this diet is considered to induce only a mild B-
vitamin deficiency.
It should be noted that the present experiments were
conducted in different labs, under somewhat different
experimental conditions (e.g. time, animal supplier, diet
manufacturer, experimental design), that might have
been responsible for small variations in absolute plasma
DHA concentration between the two experiments. How-
ever, despite the differences in experimental conditions,
the results from both experiments are highly consistent
and show a robust effect of dietary B-vitamins on plasma
DHA concentration.
The methylation of PE to PC by PEMT requires the
methyl donor SAM. This reaction is not only influenced
by the availability of SAM, but is also inhibited by SAH;
the ratio of SAM to SAH therefore affects the activity of
PEMT [8]. Moreover, SAH is hydrolyzed to homocyst-
eine via a reversible reaction: thus excess homocysteine
will result in increased SAH, thereby inhibiting PEMT
[22]. Folate, vitamin B-12, and vitamin B-6 could en-
hance PEMT activity both by reducing homocysteine
levels and by increasing methionine levels, resulting in
an increased SAM to SAH ratio, and thus an increased
methylation capacity. Both experiments revealed a sig-
nificant inverse correlation between plasma homocyst-
eine and plasma DHA concentrations. This correlation
suggests that the observed effects of B-vitamins on
plasma DHA concentration may be explained by the
effects of these vitamins on methylation capacity and
subsequent enhancement of PC synthesis by the PEMT
pathway. Because PC species generated by the PEMT
pathway are rich in PUFAs, especially DHA [10,14,15],
and because the PEMT pathway influences secretion of
VLDL from the liver [12,13], the PEMT pathway may
contribute to transport of DHA from the liver to periph-
eral tissues. This hypothesis is supported by findings
from Zeisel et al., who investigated lipid metabolism in
PEMT knockout mice and found diminished plasma
levels of DHA in adult knockout animals [9]. In a subse-
quent study, brains from fetuses (embryonic day 17)
derived from PEMT knockout dams had lower levels of
DHA in several phospholipid species in the brain as
compared to wild type controls [16]. In addition, results
of a recent human study even suggest that plasma PC-
DHA can be used as a marker for in vivo hepatic PEMT
activity [23].
The present results show that concurrent dietary fol-
ate, vitamin B-12, and vitamin B-6 deficiency can lower
plasma DHA concentration, which is in line with three
previous experiments investigating effects of deficiencies
of single B-vitamins in rats. Durand et al. found that
dietary folate deficiency reduces relative n3 PUFA levels
of the plasma total lipid fraction in rats [4]. In an early
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rat liver and brain were changed by long term (20 weeks)
dietary vitamin B-12 deficiency [5]. Dietary vitamin B-6
deficiency was also found to decrease the proportion of
PUFAs in the phospholipid fractions of various rat tis-
sues [6]. In addition to the observations on the effects of
B-vitamin deficiency, the present results indicate that
plasma DHA concentrations can be enhanced by com-
bined supplementation with high levels of these vita-
mins. Pita and Delgado previously also found a rise in
the proportion of DHA in various lipid fractions in
plasma and other tissues after daily folate administration
in rats for 15 days [24]. In that study, folate was admi-
nistered intramuscularly (500 μg/kg body weight as 5-
methyltetrahydrofolate). Notwithstanding the different
route of administration, this intramuscular dose falls in
the dietary supplementation range used in the present
study, i.e. approximately 200 and 800 μg folate per kg
body weight per day for, respectively, the B-vitamin-
enriched and B-vitamin-high diet.
The interdependence between B-vitamin intake or sta-
tus, homocysteine, and DHA status is also suggested by
several studies in humans. In a multicenter trial in preg-
nant women, oral folate supplementation (400 μg/day)
was associated with a minimal but significant increase in
maternal plasma DHA level in the phospholipid faction
when compared to the control subjects over time [25].
Crowe et al., however, observed no change in relative
DHA level in plasma PC after supplementation of folate
(1000 μg/day), vitamin B-12 (500 μg/day), and B-6
(10 mg/day) for two years to older individuals [26]. The
discrepancy between these results and those of the
present preclinical study might be explained by the rela-
tive considerable higher dose of folate used in the
present study. Additionally, analysis of the percentage of
DHA in one phospholipid fraction, as was performed by
Crowe et al., is an essentially different parameter than
the absolute DHA concentration of the total lipid frac-
tion measured in the present experiment. In accordance
with the present results, several clinical studies have
shown a negative correlation between plasma, serum, or
erythrocyte phospholipid DHA content and plasma
levels of homocysteine [1-3], SAH [3], or SAM:SAH
ratio [23]. Moreover, two clinical studies in men indi-
cated a positive correlation either between plasma DHA
concentration and erythrocyte folate level [27] or plasma
phospholipid DHA concentration and serum vitamin B-
12 level [1]. In the latter study, plasma phospholipid
DHA did not correlate with serum folate [1].
All three B-vitamins are necessary for methylation
capacity. Folate (as 5-methyltetrahydrofolate) and vita-
min B-12 are cofactors in the remethylation of homo-
cysteine to methionine, from which SAM is
subsequently regenerated. Vitamin B-6 is involved infacilitating the reversible conversion of serine to glycine,
which ultimately can generate 5-methyltetrahydrofolate,
i.e. the methyl donor for the remethylation of homocyst-
eine to methionine. Vitamin B-6 is also the cofactor for
the transsulfuration reaction responsible for the irrevers-
ible conversion of homocysteine to cysteine, and hence
the clearance of homocysteine. It can be speculated that
the effects of the three B-vitamins acting together have a
greater impact on PC metabolism via PEMT than each
B-vitamin individually. Nevertheless, it should also be
noted that the exact mechanism(s) by which the three
B-vitamins could have increased plasma DHA concen-
tration is not fully understood and that the relative con-
tribution of PEMT activity to total plasma DHA
concentration is unknown. To elucidate this, additional
experiments are required in which additional parameters
could be measured, e.g. plasma and tissue levels of B-
vitamins, SAM, SAH, and phospholipid species.
Recently, we demonstrated that rat plasma choline
concentration is also dependent on dietary intake of the
three B-vitamins, possibly mediated by enhancing
methylation capacity and hence PC synthesis [28]. Be-
cause levels of DHA [29-31] and choline [32,33] in the
brain are affected by their plasma concentrations, sup-
plemental dietary B-vitamins could ultimately sustain
brain DHA and choline levels. This may be relevant in
conditions such as Alzheimer’s disease, that are asso-
ciated with lower plasma and/or brain levels of DHA
[34,35], choline [36], and concurrent B-vitamin deficien-
cies [37,38].Conclusion
The present study shows that concurrently varying the
dietary intake of folic acid, vitamin B-12, and vitamin B-
6 can influence plasma concentration of DHA. Poor
dietary intake of the three B-vitamins causes plasma
DHA to decrease and this decrease can be abolished
through dietary supplementation with these vitamins.
Furthermore, plasma DHA concentrations can be
enhanced by supplemental intake of these B-vitamins
exceeding normal dietary recommendations.
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